27.02.2019

ARS sings an agreement with a Russian company to register its fixed combination of Chlorphenamine 2 mg + Paracetamol 500 mg + Phenylephrine 10 mg + Caffeine 30 mg in tablets. The medicine is a full analogue of Rinza® that is getting the status of a twenty-year-old drug in Russia and, therefore, the generic can be licensed without performing a local bioequivalence study.